Literature DB >> 3702212

Toward individual prognosis of IgA nephropathy.

J R Beukhof, O Kardaun, W Schaafsma, K Poortema, A J Donker, P J Hoedemaeker, G K van der Hem.   

Abstract

The individual prognosis of adult IgA nephropathy patients was studied using the proportional hazards model for the time from biopsy until endstage renal disease. After selection of the most relevant prognostic factors, the 75 patients were stratified with respect to hypertension and its treatment. In these strata, individual prognosis was based on the initial age-adjusted glomerular filtration rate, the initial proteinuria, the presence/absence of gross hematuria, and the presence/absence of microscopic hematuria. Using the scores of a patient on these variables, the probability of surviving any given period of time can be estimated either graphically or by calculation. Prediction is feasible up to about 10 years. Attention has been given to supply all relevant estimates with confidence limits. For each patient the estimated 5-year survival probability as predicted by the model was compared with the actual outcome.

Entities:  

Mesh:

Year:  1986        PMID: 3702212     DOI: 10.1038/ki.1986.33

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

Review 1.  Recognition and management of IgA nephropathy.

Authors:  L S Ibels; A Z Gyory; R J Caterson; C A Pollock; J F Mahony; D A Waugh; S Coulshed
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

2.  Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.

Authors:  Ruitong Gao; Wei Wu; Yubing Wen; Xuemei Li
Journal:  Int Urol Nephrol       Date:  2017-03-27       Impact factor: 2.370

Review 3.  Do genetic factors play a role in Berger's disease?

Authors:  M Levy
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

4.  Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy.

Authors:  Norio Ieiri; Osamu Hotta; Toshinobu Sato; Yoshio Taguma
Journal:  Clin Exp Nephrol       Date:  2011-09-13       Impact factor: 2.801

5.  Predicting the risk for dialysis or death in IgA nephropathy.

Authors:  François Berthoux; Hesham Mohey; Blandine Laurent; Christophe Mariat; Aida Afiani; Lise Thibaudin
Journal:  J Am Soc Nephrol       Date:  2011-01-21       Impact factor: 10.121

6.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.

Authors:  H Yoshida; T Mitarai; T Kawamura; T Kitajima; Y Miyazaki; R Nagasawa; Y Kawaguchi; H Kubo; I Ichikawa; O Sakai
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group.

Authors:  R J Hogg; F G Silva; R J Wyatt; J S Reisch; J C Argyle; D A Savino
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

8.  Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy.

Authors:  Satoshi Oshima; Osamu Kawamura
Journal:  Clin Exp Nephrol       Date:  2008-03-08       Impact factor: 2.801

Review 9.  An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy.

Authors:  Ron Hogg
Journal:  Pediatr Nephrol       Date:  2021-05-13       Impact factor: 3.714

10.  A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.

Authors:  Masashi Goto; Kenji Wakai; Takashi Kawamura; Masahiko Ando; Masayuki Endoh; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2009-06-10       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.